261 related articles for article (PubMed ID: 15001696)
1. 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.
Brenner W; Aicher A; Eckey T; Massoudi S; Zuhayra M; Koehl U; Heeschen C; Kampen WU; Zeiher AM; Dimmeler S; Henze E
J Nucl Med; 2004 Mar; 45(3):512-8. PubMed ID: 15001696
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.
Aicher A; Brenner W; Zuhayra M; Badorff C; Massoudi S; Assmus B; Eckey T; Henze E; Zeiher AM; Dimmeler S
Circulation; 2003 Apr; 107(16):2134-9. PubMed ID: 12695305
[TBL] [Abstract][Full Text] [Related]
3. In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.
Caveliers V; De Keulenaer G; Everaert H; Van Riet I; Van Camp G; Verheye S; Roland J; Schoors D; Franken PR; Schots R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):61-6. PubMed ID: 17372574
[TBL] [Abstract][Full Text] [Related]
4. Indium-111 oxine labelling affects the cellular integrity of haematopoietic progenitor cells.
Nowak B; Weber C; Schober A; Zeiffer U; Liehn EA; von Hundelshausen P; Reinartz P; Schaefer WM; Buell U
Eur J Nucl Med Mol Imaging; 2007 May; 34(5):715-721. PubMed ID: 17096094
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose.
Templin C; Kotlarz D; Faulhaber J; Schnabel S; Grote K; Salguero G; Luchtefeld M; Hiller KH; Jakob P; Naim HY; Schieffer B; Hilfiker-Kleiner D; Landmesser U; Limbourg FP; Drexler H
J Mol Cell Cardiol; 2008 Sep; 45(3):394-403. PubMed ID: 18671980
[TBL] [Abstract][Full Text] [Related]
6. Minimal engraftment of human CD34+ cells mobilized from healthy donors in the infarcted heart of athymic nude rats.
Sondergaard CS; Bonde J; Dagnaes-Hansen F; Nielsen JM; Zachar V; Holm M; Hokland P; Pedersen L
Stem Cells Dev; 2009; 18(6):845-56. PubMed ID: 18991484
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.
Hou D; Youssef EA; Brinton TJ; Zhang P; Rogers P; Price ET; Yeung AC; Johnstone BH; Yock PG; March KL
Circulation; 2005 Aug; 112(9 Suppl):I150-6. PubMed ID: 16159808
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.
Iwasaki H; Kawamoto A; Ishikawa M; Oyamada A; Nakamori S; Nishimura H; Sadamoto K; Horii M; Matsumoto T; Murasawa S; Shibata T; Suehiro S; Asahara T
Circulation; 2006 Mar; 113(10):1311-25. PubMed ID: 16534028
[TBL] [Abstract][Full Text] [Related]
9. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium.
Schächinger V; Aicher A; Döbert N; Röver R; Diener J; Fichtlscherer S; Assmus B; Seeger FH; Menzel C; Brenner W; Dimmeler S; Zeiher AM
Circulation; 2008 Sep; 118(14):1425-32. PubMed ID: 18794392
[TBL] [Abstract][Full Text] [Related]
10. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.
Blocklet D; Toungouz M; Berkenboom G; Lambermont M; Unger P; Preumont N; Stoupel E; Egrise D; Degaute JP; Goldman M; Goldman S
Stem Cells; 2006 Feb; 24(2):333-6. PubMed ID: 16223854
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[(18)F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography.
Zhang Y; Dasilva JN; Hadizad T; Thorn S; Kuraitis D; Renaud JM; Ahmadi A; Kordos M; Dekemp RA; Beanlands RS; Suuronen EJ; Ruel M
Cell Transplant; 2012; 21(9):1821-35. PubMed ID: 22469629
[TBL] [Abstract][Full Text] [Related]
12. In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis.
Gholamrezanezhad A; Mirpour S; Bagheri M; Mohamadnejad M; Alimoghaddam K; Abdolahzadeh L; Saghari M; Malekzadeh R
Nucl Med Biol; 2011 Oct; 38(7):961-7. PubMed ID: 21810549
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction.
Ayala-Lugo A; Tavares AM; Paz AH; Alegretti A; Miquelito L; Bock H; Giugliani R; Clausell N; Cirne-Lima E; Rohde LE
Cell Transplant; 2011; 20(3):407-19. PubMed ID: 21535915
[TBL] [Abstract][Full Text] [Related]
14. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.
Kawamoto A; Iwasaki H; Kusano K; Murayama T; Oyamada A; Silver M; Hulbert C; Gavin M; Hanley A; Ma H; Kearney M; Zak V; Asahara T; Losordo DW
Circulation; 2006 Nov; 114(20):2163-9. PubMed ID: 17075009
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.
Barbash IM; Chouraqui P; Baron J; Feinberg MS; Etzion S; Tessone A; Miller L; Guetta E; Zipori D; Kedes LH; Kloner RA; Leor J
Circulation; 2003 Aug; 108(7):863-8. PubMed ID: 12900340
[TBL] [Abstract][Full Text] [Related]
16. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.
Gao J; Dennis JE; Muzic RF; Lundberg M; Caplan AI
Cells Tissues Organs; 2001; 169(1):12-20. PubMed ID: 11340257
[TBL] [Abstract][Full Text] [Related]
17. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
18. Myocardial infarction does not affect circulating haematopoietic stem and progenitor cell self-renewal ability in a rat model.
Kröpfl JM; Spengler CM; Frobert A; Ajalbert G; Giraud MN
Exp Physiol; 2018 Jan; 103(1):1-8. PubMed ID: 29094480
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells provide better results than hematopoietic precursors for the treatment of myocardial infarction.
Armiñán A; Gandía C; García-Verdugo JM; Lledó E; Trigueros C; Ruiz-Saurí A; Miñana MD; Solves P; Payá R; Montero JA; Sepúlveda P
J Am Coll Cardiol; 2010 May; 55(20):2244-53. PubMed ID: 20466205
[TBL] [Abstract][Full Text] [Related]
20. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction.
Doyle B; Kemp BJ; Chareonthaitawee P; Reed C; Schmeckpeper J; Sorajja P; Russell S; Araoz P; Riederer SJ; Caplice NM
J Nucl Med; 2007 Oct; 48(10):1708-14. PubMed ID: 17909258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
